Shoujiang Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shoujiang Wei has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Pengcheng Ye
Department of Gastrointestinal Surgery, the Affiliated Hospital of North Sichuan Medical College
4 shared publicationsJin Tang
Department of Gastrointestinal Surgery, the Affiliated Hospital of North Sichuan Medical College
3 shared publications- Qijun Lv
Department of Gastrointestinal Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, People’s Republic of China
3 shared publications Junsong Yang
Department of Gastrointestinal Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China, hospital-nsmc.com.cn
2 shared publicationsJunyi Li
Department of Gastrointestinal Surgery, the Affiliated Hospital of North Sichuan Medical College
2 shared publicationsMing He
Graduate School of North Sichuan Medical College, Nanchong, 637000, People’s Republic of China
2 shared publications
Latest Publications
- Open Access
- 3 February 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16
Single-incision laparoscopic surgery with transabdominal postperitoneal approach for synchronous ileocecal and sigmoid cancers: a case report
Surgical operation is the most commonly used treatment for colorectal cancer, and the treatment of synchronous multiple primary colorectal cancer is also mainly based on surgical operation. Retroperitoneal Approach for total colectomy in minimally invasive treatment of synchronous multiple colon cancer has reported. But concurrent multi-segmental resection for multiple primary colorectal cancers via a single-incision laparoscopic surgery with transabdominal postperitoneal approach has not previously been reported. We would like to share a case of radical resection of ileocecal cancer and sigmoid colon cancer via transabdominal postperitoneal approach under single-incision laparoscopy. A 72-year-old female presented to the clinic with a progressive alteration in bowel habits and stool consistency over the past year, accompanied by fatigue during the preceding month. The diagnoses included ileocecal cancer, sigmoid colon cancer, severe anemia, coronary atherosclerosis and incomplete intestinal obstruction. Blood transfusion was administered to correct the anemic condition. Given the patient’s comorbidities, including severe anemia and coronary atherosclerosis, along with a body mass index of 20.8 kg/m², a single-incision laparoscopic surgery with transabdominal postperitoneal approach was selected.
- 3 February 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16
Open AccessSingle-incision laparoscopic surgery with transabdominal postperitoneal approach for synchronous ileocecal and sigmoid cancers: a case report
Surgical operation is the most commonly used treatment for colorectal cancer, and the treatment of synchronous multiple primary colorectal cancer is also mainly based on surgical operation. Retroperitoneal Approach for total colectomy in minimally invasive treatment of synchronous multiple colon cancer has reported. But concurrent multi-segmental resection for multiple primary colorectal cancers via a single-incision laparoscopic surgery with transabdominal postperitoneal approach has not previously been reported. We would like to share a case of radical resection of ileocecal cancer and sigmoid colon cancer via transabdominal postperitoneal approach under single-incision laparoscopy. A 72-year-old female presented to the clinic with a progressive alteration in bowel habits and stool consistency over the past year, accompanied by fatigue during the preceding month. The diagnoses included ileocecal cancer, sigmoid colon cancer, severe anemia, coronary atherosclerosis and incomplete intestinal obstruction. Blood transfusion was administered to correct the anemic condition. Given the patient’s comorbidities, including severe anemia and coronary atherosclerosis, along with a body mass index of 20.8 kg/m², a single-incision laparoscopic surgery with transabdominal postperitoneal approach was selected.
- Open Access
- 13 January 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (4) , 9015-9023
Single-incision laparoscopic surgery with transabdominal retroperitoneal approach (SILS-TRPA): a novel surgical strategy for sigmoid colon/upper rectal cancer
Background: Single-incision laparoscopic surgery (SILS) is an established minimally invasive option for radical colorectal cancer resection, but its wider adoption is limited by technical challenges.This study introduces an innovative SILS technique with a transabdominal retroperitoneal approach (TRPA) to enhance its feasibility. Objective: This study aimed to evaluate the feasibility and safety of single-incision laparoscopic surgery with transabdominal retroperitoneal approach (SILS-TRPA) for the treatment of patients with sigmoid colon/rectal cancer. Materials and Methods: This prospective IDEAL stage 1 study included 36 patients at the affiliated hospital of North Sichuan Medical College from 12 October 2022 to 31 December 2024. All procedures were performed by the same surgical team. The short-term efficacy and safety of this surgical strategy were preliminarily studied by collecting and analyzing the demographic information, clinical characteristics, surgical outcomes and postoperative recovery indicators of this group of patients. Results: The median age of patients was 70.6 years (IQR 61–77), with a median body mass index of 24.8 kg/m 2 (IQR 21.0–28.2). Twenty-four patients had underlying respiratory conditions of chronic obstructive pulmonary disease (COPD). All patients successfully completed the SILS without conversion to laparotomy. The median total operating time was 118.75 minutes. The mean arterial carbon dioxide pressure during the extraperitoneal phase was significantly lower (32.7 mmHg) compared to the intraperitoneal phase (45.3 mmHg). The median estimated blood loss was 19.20 mL, with no blood transfusions required and no significant operative complications reported. Pathological analysis revealed that 77.78% of patients had advanced disease (stage III), and the average number of harvested lymph nodes was 21.32. Postoperatively, patients experienced a mean time to ambulation of 1.38 days and a mean hospital stay of 6.17 days. Complications occurred in 11patients (30.56%), which were primarily classified as grade I and II according to the Clavien–Dindo classification. Notably, there were no cases of anastomotic leakage or severe complications. Conclusion: The SILS-TRPA for sigmoid colon/upper rectal cancer demonstrates effective oncological management with minimal complications and a favorable recovery profile. The results suggest that this technique is a viable option for patients with sigmoid colon/upper rectal cancer, particularly in those with significant comorbidities.
- 13 January 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (4) , 9015-9023
Open AccessSingle-incision laparoscopic surgery with transabdominal retroperitoneal approach (SILS-TRPA): a novel surgical strategy for sigmoid colon/upper rectal cancer
Background: Single-incision laparoscopic surgery (SILS) is an established minimally invasive option for radical colorectal cancer resection, but its wider adoption is limited by technical challenges.This study introduces an innovative SILS technique with a transabdominal retroperitoneal approach (TRPA) to enhance its feasibility. Objective: This study aimed to evaluate the feasibility and safety of single-incision laparoscopic surgery with transabdominal retroperitoneal approach (SILS-TRPA) for the treatment of patients with sigmoid colon/rectal cancer. Materials and Methods: This prospective IDEAL stage 1 study included 36 patients at the affiliated hospital of North Sichuan Medical College from 12 October 2022 to 31 December 2024. All procedures were performed by the same surgical team. The short-term efficacy and safety of this surgical strategy were preliminarily studied by collecting and analyzing the demographic information, clinical characteristics, surgical outcomes and postoperative recovery indicators of this group of patients. Results: The median age of patients was 70.6 years (IQR 61–77), with a median body mass index of 24.8 kg/m 2 (IQR 21.0–28.2). Twenty-four patients had underlying respiratory conditions of chronic obstructive pulmonary disease (COPD). All patients successfully completed the SILS without conversion to laparotomy. The median total operating time was 118.75 minutes. The mean arterial carbon dioxide pressure during the extraperitoneal phase was significantly lower (32.7 mmHg) compared to the intraperitoneal phase (45.3 mmHg). The median estimated blood loss was 19.20 mL, with no blood transfusions required and no significant operative complications reported. Pathological analysis revealed that 77.78% of patients had advanced disease (stage III), and the average number of harvested lymph nodes was 21.32. Postoperatively, patients experienced a mean time to ambulation of 1.38 days and a mean hospital stay of 6.17 days. Complications occurred in 11patients (30.56%), which were primarily classified as grade I and II according to the Clavien–Dindo classification. Notably, there were no cases of anastomotic leakage or severe complications. Conclusion: The SILS-TRPA for sigmoid colon/upper rectal cancer demonstrates effective oncological management with minimal complications and a favorable recovery profile. The results suggest that this technique is a viable option for patients with sigmoid colon/upper rectal cancer, particularly in those with significant comorbidities.
- Open Access
- 1 January 2026
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2026 (1)
Effect of Integrated Lecture‐, Case‐, and Problem‐Based Learning on Critical Thinking and Clinical Competence in Gastrointestinal Surgery Trainees: A Randomized Controlled Trial
Background: Enhancing clinical thinking and competence is central to gastrointestinal surgical training. This study is aimed at evaluating the effectiveness of an integrated instructional model combining lecture‐based learning (LBL), problem‐based learning (PBL), and case‐based learning (CBL) in gastrointestinal surgical training. Methods: This prospective randomized controlled trial was conducted at the Affiliated Hospital of North Sichuan Medical College, China, from September to November 2024. A total of 120 gastrointestinal surgical trainees, including final‐year medical interns and first‐year surgical residents, were randomly assigned (1:1:1) to the LBL, PBL + CBL, or integrated LBL + PBL + CBL groups using a computer‐generated sequence, with allocation concealed by an independent assistant. After completing an 8‐week standardized curriculum delivered by the same teaching team, the following outcomes were assessed: critical thinking ability using the Chinese version of the California critical thinking disposition inventory (CTDI‐CV); theoretical knowledge through written and oral examinations; learning efficiency (study time and task completion rate) and satisfaction; and clinical competence assessed via the miniclinical evaluation exercise (Mini‐CEX). Data were analyzed using IBM SPSS Statistics with one‐way analysis of variance, and statistical significance was set at p < 0.05. Results: The integrated LBL + PBL + CBL groups achieved the highest CTDI‐CV total scores, theoretical knowledge performance, and Mini‐CEX scores compared with the other groups ( p < 0.05). Despite reporting the shortest weekly study time, the integrated group attained the highest task completion rate and learner satisfaction score ( p < 0.05). Conclusion: The integrated LBL + PBL + CBL approach enhances efficiency and is well‐suited for advancing clinical competence in surgical training. Trial registration: Chinese Clinical Trial Registry (ChiCTR2000041569).
- 1 January 2026
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2026 (1)
Open AccessEffect of Integrated Lecture‐, Case‐, and Problem‐Based Learning on Critical Thinking and Clinical Competence in Gastrointestinal Surgery Trainees: A Randomized Controlled Trial
Background: Enhancing clinical thinking and competence is central to gastrointestinal surgical training. This study is aimed at evaluating the effectiveness of an integrated instructional model combining lecture‐based learning (LBL), problem‐based learning (PBL), and case‐based learning (CBL) in gastrointestinal surgical training. Methods: This prospective randomized controlled trial was conducted at the Affiliated Hospital of North Sichuan Medical College, China, from September to November 2024. A total of 120 gastrointestinal surgical trainees, including final‐year medical interns and first‐year surgical residents, were randomly assigned (1:1:1) to the LBL, PBL + CBL, or integrated LBL + PBL + CBL groups using a computer‐generated sequence, with allocation concealed by an independent assistant. After completing an 8‐week standardized curriculum delivered by the same teaching team, the following outcomes were assessed: critical thinking ability using the Chinese version of the California critical thinking disposition inventory (CTDI‐CV); theoretical knowledge through written and oral examinations; learning efficiency (study time and task completion rate) and satisfaction; and clinical competence assessed via the miniclinical evaluation exercise (Mini‐CEX). Data were analyzed using IBM SPSS Statistics with one‐way analysis of variance, and statistical significance was set at p < 0.05. Results: The integrated LBL + PBL + CBL groups achieved the highest CTDI‐CV total scores, theoretical knowledge performance, and Mini‐CEX scores compared with the other groups ( p < 0.05). Despite reporting the shortest weekly study time, the integrated group attained the highest task completion rate and learner satisfaction score ( p < 0.05). Conclusion: The integrated LBL + PBL + CBL approach enhances efficiency and is well‐suited for advancing clinical competence in surgical training. Trial registration: Chinese Clinical Trial Registry (ChiCTR2000041569).
- Open Access
- 15 December 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Oncology
- Vol. 17 (12)
Exosomal miR-191 promotes colorectal cancer progression by inducing M2 macrophage polarization and inhibiting ferroptosis
BACKGROUND Multiple exosomal microRNAs were reported to have a significant role in colorectal cancer (CRC) cells. The function and mechanism of exosomal miR-191 in CRC have not been clearly elucidated. AIM To explore the roles of miR-191 in CRC. METHODS Supernatant exosomes from CRC cells were extracted and identified. After coculture, macrophage polarization was determined using flow cytometry for the markers cluster of differentiation (CD) 68 and CD163, enzyme-linked immunosorbent assay for the cytokines interleukin (IL)-4 and IL-10, western blotting for chitinase-like protein 3 and arginase-1 expression, and immunofluorescent staining for 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate. Reactive oxygen species (ROS) level, ferroptosis-related proteins (SLC7A11 and GPX4 ), and apoptosis were determined with flow cytometry, western blotting, and TUNEL staining. We performed in vivo experiments to determine the function of exosomal miR-191 and M2 macrophage polarization. RESULTS We successfully isolated exosomes from CRC cells. Inhibition of miR-191 in CRC cells suppressed M2 polarization of macrophages. After coculture of macrophages, inhibition of miR-191 induced ROS production, ferroptosis, and apoptosis of CRC cells. Silencing of exosomal miR-191 from CRC cells prevented M2 polarization of macrophages, and weakened CRC development by inducing ferroptosis. Exosomal miR-191 accelerated cancer progression in CRC nude mice by promoting M2 polarization of macrophages. CONCLUSION Inhibition of exosomal miR-191 attenuated CRC progression by inducing ferroptosis in macrophages. This study revealed a novel mechanism by which exosomal miR-191 modulates the tumor microenvironment.
- 15 December 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Oncology
- Vol. 17 (12)
Open AccessExosomal miR-191 promotes colorectal cancer progression by inducing M2 macrophage polarization and inhibiting ferroptosis
BACKGROUND Multiple exosomal microRNAs were reported to have a significant role in colorectal cancer (CRC) cells. The function and mechanism of exosomal miR-191 in CRC have not been clearly elucidated. AIM To explore the roles of miR-191 in CRC. METHODS Supernatant exosomes from CRC cells were extracted and identified. After coculture, macrophage polarization was determined using flow cytometry for the markers cluster of differentiation (CD) 68 and CD163, enzyme-linked immunosorbent assay for the cytokines interleukin (IL)-4 and IL-10, western blotting for chitinase-like protein 3 and arginase-1 expression, and immunofluorescent staining for 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate. Reactive oxygen species (ROS) level, ferroptosis-related proteins (SLC7A11 and GPX4 ), and apoptosis were determined with flow cytometry, western blotting, and TUNEL staining. We performed in vivo experiments to determine the function of exosomal miR-191 and M2 macrophage polarization. RESULTS We successfully isolated exosomes from CRC cells. Inhibition of miR-191 in CRC cells suppressed M2 polarization of macrophages. After coculture of macrophages, inhibition of miR-191 induced ROS production, ferroptosis, and apoptosis of CRC cells. Silencing of exosomal miR-191 from CRC cells prevented M2 polarization of macrophages, and weakened CRC development by inducing ferroptosis. Exosomal miR-191 accelerated cancer progression in CRC nude mice by promoting M2 polarization of macrophages. CONCLUSION Inhibition of exosomal miR-191 attenuated CRC progression by inducing ferroptosis in macrophages. This study revealed a novel mechanism by which exosomal miR-191 modulates the tumor microenvironment.
- Open Access
- 9 October 2025
- Published by Springer Nature in European Journal of Medical Research
- Vol. 30 (1) , 1-8
Superselective transarterial chemoembolization (SSTACE) as second-line conversion therapy for locally advanced unresectable gastric or gastroesophageal junction adenocarcinoma: a preliminary retrospective cohort study
In patients with locally advanced unresectable gastric or gastroesophageal junction adenocarcinoma, conversion therapy has shown suboptimal efficacy, typically resulting in stable disease (SD) or progressive disease (PD) leading to low surgical conversion rates and unfavorable prognosis. This study seeks to assess the efficacy and safety of superselective transarterial chemoembolization (SSTACE) in treating this specific patient cohort. This retrospective cohort study analyzed patients diagnosed with locally advanced unresectable gastric cancer (GC) or gastroesophageal junction (GEJ) adenocarcinoma at the Affiliated Hospital of North Sichuan Medical College between January 2019 and March 2025. All of them underwent a single session of SSTACE, followed by an assessment of surgical resectability one month later. Patients considered resectable underwent gastrectomy with D2 lymphadenectomy, while those deemed unresectable continued with palliative chemotherapy regimens consistent with their pre-SSTACE systemic protocols. The primary endpoint was R0 resection rate, with secondary endpoints, including the postoperative complication rate, tumor regression rate post-chemoembolization, and pathological complete response (pCR) rate. This retrospective study analyzed 16 patients who underwent SSTACE. Tumor regression was observed in 12 patients, eight of whom met the criteria for partial response. In addition, 12 patients who exhibited regression subsequently achieved R0 resection. Pathological complete response (pCR) was observed in three patients. In terms of safety, all adverse events related to SSTACE in the cohort were manageable. The most common adverse events were nausea (43.8%, 7/16), vomiting (37.5%, 6/16), and abdominal pain (37.5%, 6/16). No instances of hepatic dysfunction were reported. In addition, none of the surgical patients experienced major postoperative complications. SSTACE could potentially offer a novel therapeutic approach for patients with locally advanced unresectable GC or GEJ cancer who have shown limited response to systemic chemotherapy/immunotherapy, characterized by SD or PD. This treatment may increase the likelihood of achieving surgical conversion and R0 resection rates while upholding a favorable safety profile.
- 9 October 2025
- Published by Springer Nature in European Journal of Medical Research
- Vol. 30 (1) , 1-8
Open AccessSuperselective transarterial chemoembolization (SSTACE) as second-line conversion therapy for locally advanced unresectable gastric or gastroesophageal junction adenocarcinoma: a preliminary retrospective cohort study
In patients with locally advanced unresectable gastric or gastroesophageal junction adenocarcinoma, conversion therapy has shown suboptimal efficacy, typically resulting in stable disease (SD) or progressive disease (PD) leading to low surgical conversion rates and unfavorable prognosis. This study seeks to assess the efficacy and safety of superselective transarterial chemoembolization (SSTACE) in treating this specific patient cohort. This retrospective cohort study analyzed patients diagnosed with locally advanced unresectable gastric cancer (GC) or gastroesophageal junction (GEJ) adenocarcinoma at the Affiliated Hospital of North Sichuan Medical College between January 2019 and March 2025. All of them underwent a single session of SSTACE, followed by an assessment of surgical resectability one month later. Patients considered resectable underwent gastrectomy with D2 lymphadenectomy, while those deemed unresectable continued with palliative chemotherapy regimens consistent with their pre-SSTACE systemic protocols. The primary endpoint was R0 resection rate, with secondary endpoints, including the postoperative complication rate, tumor regression rate post-chemoembolization, and pathological complete response (pCR) rate. This retrospective study analyzed 16 patients who underwent SSTACE. Tumor regression was observed in 12 patients, eight of whom met the criteria for partial response. In addition, 12 patients who exhibited regression subsequently achieved R0 resection. Pathological complete response (pCR) was observed in three patients. In terms of safety, all adverse events related to SSTACE in the cohort were manageable. The most common adverse events were nausea (43.8%, 7/16), vomiting (37.5%, 6/16), and abdominal pain (37.5%, 6/16). No instances of hepatic dysfunction were reported. In addition, none of the surgical patients experienced major postoperative complications. SSTACE could potentially offer a novel therapeutic approach for patients with locally advanced unresectable GC or GEJ cancer who have shown limited response to systemic chemotherapy/immunotherapy, characterized by SD or PD. This treatment may increase the likelihood of achieving surgical conversion and R0 resection rates while upholding a favorable safety profile.
- Open Access
Single-port laparoscopic surgery for sigmoid colon cancer: a novel surgical strategy based on “peritoneal dome”
Aims: This study aimed to introduce a novel ‘peritoneal dome’ strategy for single-port laparoscopic surgery in patients with sigmoid colon cancer and to evaluate the feasibility and safety of this approach. Methods: A total of 12 patients at the affiliated hospital of North Sichuan Medical College from January 2022 to August 2024 were enrolled. All procedures were performed by the same surgical team. By collecting and analyzing the demographic information, clinical characteristics, surgical outcomes and postoperative recovery indicators of this group of patients, the short-term efficacy and safety of this surgical strategy were preliminarily studied. Results: The median age of patients was 72 years (range, 58-81), with a median body mass index (BMI) of 25.8 kg/m 2 (range, 22–31.2). Most patients had underlying respiratory conditions, particularly chronic obstructive pulmonary disease (COPD) (80%). All patients successfully completed the single-port laparoscopic surgery without conversion to laparotomy. The median of the total operating time was 98.80 minutes. The mean arterial carbon dioxide pressure (PaCO2) during the extraperitoneal phase was significantly lower (32.5 mmHg) compared to the intraperitoneal phase (47.1 mmHg). The median estimated blood loss was 19.20 ml, with no transfusions required and no significant operative complications reported. Pathological analysis revealed that 83.3% of patients had advanced disease (stage III), and the average number of harvested lymph nodes was 18.92. Postoperatively, patients experienced a mean time to ambulation of 1.25 days and a mean hospital stay of 6.17 days. Complications occurred in 33.3% of patients, primarily classified as grade I and II according to the Clavien-Dindo classification. Notably, there were no cases of anastomotic leakage or severe complications. Conclusion: The single-port laparoscopic surgery based on a “peritoneal dome” supported strategy for sigmoid colon cancer demonstrates effective oncological management with minimal complications and a favorable recovery profile. The results suggest that this technique is a viable option for patients with advanced sigmoid colon cancer, particularly in those with significant comorbidities.
Open AccessSingle-port laparoscopic surgery for sigmoid colon cancer: a novel surgical strategy based on “peritoneal dome”
Aims: This study aimed to introduce a novel ‘peritoneal dome’ strategy for single-port laparoscopic surgery in patients with sigmoid colon cancer and to evaluate the feasibility and safety of this approach. Methods: A total of 12 patients at the affiliated hospital of North Sichuan Medical College from January 2022 to August 2024 were enrolled. All procedures were performed by the same surgical team. By collecting and analyzing the demographic information, clinical characteristics, surgical outcomes and postoperative recovery indicators of this group of patients, the short-term efficacy and safety of this surgical strategy were preliminarily studied. Results: The median age of patients was 72 years (range, 58-81), with a median body mass index (BMI) of 25.8 kg/m 2 (range, 22–31.2). Most patients had underlying respiratory conditions, particularly chronic obstructive pulmonary disease (COPD) (80%). All patients successfully completed the single-port laparoscopic surgery without conversion to laparotomy. The median of the total operating time was 98.80 minutes. The mean arterial carbon dioxide pressure (PaCO2) during the extraperitoneal phase was significantly lower (32.5 mmHg) compared to the intraperitoneal phase (47.1 mmHg). The median estimated blood loss was 19.20 ml, with no transfusions required and no significant operative complications reported. Pathological analysis revealed that 83.3% of patients had advanced disease (stage III), and the average number of harvested lymph nodes was 18.92. Postoperatively, patients experienced a mean time to ambulation of 1.25 days and a mean hospital stay of 6.17 days. Complications occurred in 33.3% of patients, primarily classified as grade I and II according to the Clavien-Dindo classification. Notably, there were no cases of anastomotic leakage or severe complications. Conclusion: The single-port laparoscopic surgery based on a “peritoneal dome” supported strategy for sigmoid colon cancer demonstrates effective oncological management with minimal complications and a favorable recovery profile. The results suggest that this technique is a viable option for patients with advanced sigmoid colon cancer, particularly in those with significant comorbidities.
- 4 September 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 1-14
Perioperative outcomes of robot-assisted versus laparoscopic distal gastrectomy for gastric cancer: a systematic review and meta-analysis of propensity score matching studies
The aim of this meta-analysis was to compare the efficacy of robot distal gastrectomy (RDG) versus laparoscopic distal gastrectomy (LDG) for gastric cancer. Studies included only those that utilized propensity score matching (PSM). A systematic literature search was conducted in several major global databases, including PubMed, Embase, and Google Scholar, up to June 2024. Articles were screened based on predefined inclusion and exclusion criteria. Baseline data and primary and secondary outcome measures (e.g., operative time, estimated blood loss, lymph-node yield dissection, length of hospital stay, and time to first flatus) were extracted. The quality of PSM studies was assessed using the ROBINS-I, and data were analyzed using Review Manager 5.4.1 software. A total of 12 propensity score-matched studies involving 3688 patients were included in this meta-analysis. Robot-assisted surgery resulted in a longer operative time (WMD 30.64 min, 95% CI 15.63 – 45.66; p < 0.0001), less estimated blood loss (WMD 29.54 mL, 95% CI − 47.14 − 11.94; p = 0.001), more lymph-node yield (WMD 5.14, 95% CI 2.39 − 7.88; p = 0.0002), and a shorter hospital stay (WMD − 0.36, 95% CI − 0.60 − 0.12; p = 0.004) compared with laparoscopic surgery. There were no significant differences between the two surgical methods in terms of time to first flatus, overall complications, and major complications. Robot distal gastrectomy for gastric cancer reduces intraoperative blood loss, increases lymph-node yield, and shortens hospital stay compared with laparoscopic surgery, despite a longer operative time. There are no significant differences in time to first flatus and complication rates between the two groups.
- 4 September 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 1-14
Perioperative outcomes of robot-assisted versus laparoscopic distal gastrectomy for gastric cancer: a systematic review and meta-analysis of propensity score matching studies
The aim of this meta-analysis was to compare the efficacy of robot distal gastrectomy (RDG) versus laparoscopic distal gastrectomy (LDG) for gastric cancer. Studies included only those that utilized propensity score matching (PSM). A systematic literature search was conducted in several major global databases, including PubMed, Embase, and Google Scholar, up to June 2024. Articles were screened based on predefined inclusion and exclusion criteria. Baseline data and primary and secondary outcome measures (e.g., operative time, estimated blood loss, lymph-node yield dissection, length of hospital stay, and time to first flatus) were extracted. The quality of PSM studies was assessed using the ROBINS-I, and data were analyzed using Review Manager 5.4.1 software. A total of 12 propensity score-matched studies involving 3688 patients were included in this meta-analysis. Robot-assisted surgery resulted in a longer operative time (WMD 30.64 min, 95% CI 15.63 – 45.66; p < 0.0001), less estimated blood loss (WMD 29.54 mL, 95% CI − 47.14 − 11.94; p = 0.001), more lymph-node yield (WMD 5.14, 95% CI 2.39 − 7.88; p = 0.0002), and a shorter hospital stay (WMD − 0.36, 95% CI − 0.60 − 0.12; p = 0.004) compared with laparoscopic surgery. There were no significant differences between the two surgical methods in terms of time to first flatus, overall complications, and major complications. Robot distal gastrectomy for gastric cancer reduces intraoperative blood loss, increases lymph-node yield, and shortens hospital stay compared with laparoscopic surgery, despite a longer operative time. There are no significant differences in time to first flatus and complication rates between the two groups.
- Open Access
- 9 January 2023
- Published by Medknow in Journal of Minimal Access Surgery
- Vol. 19 (3) , 371-377
A propensity score matching investigation of short-term results of single-incision laparoscopic low anterior rectal resection via ileostomy site
Aims: The study was performed to verify the results of single-incision laparoscopic surgery (SILS) through the ileostomy site for low rectal cancer compared with conventional laparoscopic surgery (CLS). Materials and Methods: From January 2019 to November 2021, 133 patients with low rectal cancer underwent single-incision (n = 27) or conventional (n = 106) methods of low anterior rectal resection surgery with ileostomy. All patients were balanced by propensity score matching for basic information in a ratio of 1:2, resulting in 27 and 54 in SILS and CLS groups, respectively. Results: Relative to the CLS group, the SILS group exhibited fewer leucocyte changes, shorter time to first exhaust and first bowel sounds, shorter length of hospital stay and lower Visual Analogue Score on post-operative days (POD2) and POD3. Intraoperative or post-operative complications or readmissions were comparable between the two groups. The oncologic results remained consistent between the two groups other than the number of lymph nodes dissected in group no. 253. Conclusions: Single-incision laparoscopic low rectal resection surgery through the ileostomy site has advantages in terms of reduced post-operative pain, shorter post-operative exhaust time and length of hospital stay while also achieving oncologic outcomes similar to those of conventional laparoscopy. It can be an alternative procedure for patients with low rectal cancer who require ileostomy.
- 9 January 2023
- Published by Medknow in Journal of Minimal Access Surgery
- Vol. 19 (3) , 371-377
Open AccessA propensity score matching investigation of short-term results of single-incision laparoscopic low anterior rectal resection via ileostomy site
Aims: The study was performed to verify the results of single-incision laparoscopic surgery (SILS) through the ileostomy site for low rectal cancer compared with conventional laparoscopic surgery (CLS). Materials and Methods: From January 2019 to November 2021, 133 patients with low rectal cancer underwent single-incision (n = 27) or conventional (n = 106) methods of low anterior rectal resection surgery with ileostomy. All patients were balanced by propensity score matching for basic information in a ratio of 1:2, resulting in 27 and 54 in SILS and CLS groups, respectively. Results: Relative to the CLS group, the SILS group exhibited fewer leucocyte changes, shorter time to first exhaust and first bowel sounds, shorter length of hospital stay and lower Visual Analogue Score on post-operative days (POD2) and POD3. Intraoperative or post-operative complications or readmissions were comparable between the two groups. The oncologic results remained consistent between the two groups other than the number of lymph nodes dissected in group no. 253. Conclusions: Single-incision laparoscopic low rectal resection surgery through the ileostomy site has advantages in terms of reduced post-operative pain, shorter post-operative exhaust time and length of hospital stay while also achieving oncologic outcomes similar to those of conventional laparoscopy. It can be an alternative procedure for patients with low rectal cancer who require ileostomy.
- Open Access
- 1 January 2023
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 17 (2)
Comparison of the efficacy and safety of single-incision versus multi-port laparoscopic D2 lymphadenectomy for locally advanced gastric cancer: a systematic review and meta-analysis
As a cutting-edge advancement in the field of minimally invasive surgery, single-incision laparoscopic surgery (SILS) represents a significant evolution from traditional multi-port approaches toward minimizing surgical stress and optimizing cosmetic outcomes in gastrointestinal oncology. This study aimed to compare the efficacy and safety of SILS and multi-port laparoscopic surgery (MPLS) in D2 lymphadenectomy of locally advanced gastric cancer (LAGC) radical surgery, so as to provide an evidence-based basis for clinical operation selection. Following PRISMA 2020, we included studies comparing SILS and MPLS in LAGC patients undergoing D2 lymphadenectomy [PICOS: P: LAGC patients; I: SILS; C: MPLS; O: complications, lymph node yield, survival; S: randomized controlled trials (RCTs) and retrospective studies]. A systematic search was updated through September 2025 in Chinese and English databases. Risk of bias was assessed using Cochrane RoB 2.0 (RCTs) and Newcastle-Ottawa Scale (NOS) (retrospective studies). A total of 10 articles (6 RCTs and 4 retrospective studies) involving 1,892 patients were analyzed. Stratified analysis by study design showed that in the RCT subgroup (n=6), there were no significant differences in complication rates [odds ratio (OR) =0.87, P=0.18] or the number of lymph nodes dissected [standardized mean difference (SMD) =−0.08, P=0.15]. Results from the retrospective subgroup (n=4) were consistent with those of the RCTs. Across all evidence levels, SILS significantly reduced blood loss (SMD =−0.31, P<0.001) and yielded smaller incision lengths (SMD =−2.41, P<0.001). Based on the synthesis of currently available moderate-to-high quality evidence, SILS in LAGC radical resection achieves comparable oncological radicality to MPLS. While SILS significantly enhances perioperative recovery and minimally invasive benefits, the findings are subject to the inherent limitations of the included study designs.
- 1 January 2023
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 17 (2)
Open AccessComparison of the efficacy and safety of single-incision versus multi-port laparoscopic D2 lymphadenectomy for locally advanced gastric cancer: a systematic review and meta-analysis
As a cutting-edge advancement in the field of minimally invasive surgery, single-incision laparoscopic surgery (SILS) represents a significant evolution from traditional multi-port approaches toward minimizing surgical stress and optimizing cosmetic outcomes in gastrointestinal oncology. This study aimed to compare the efficacy and safety of SILS and multi-port laparoscopic surgery (MPLS) in D2 lymphadenectomy of locally advanced gastric cancer (LAGC) radical surgery, so as to provide an evidence-based basis for clinical operation selection. Following PRISMA 2020, we included studies comparing SILS and MPLS in LAGC patients undergoing D2 lymphadenectomy [PICOS: P: LAGC patients; I: SILS; C: MPLS; O: complications, lymph node yield, survival; S: randomized controlled trials (RCTs) and retrospective studies]. A systematic search was updated through September 2025 in Chinese and English databases. Risk of bias was assessed using Cochrane RoB 2.0 (RCTs) and Newcastle-Ottawa Scale (NOS) (retrospective studies). A total of 10 articles (6 RCTs and 4 retrospective studies) involving 1,892 patients were analyzed. Stratified analysis by study design showed that in the RCT subgroup (n=6), there were no significant differences in complication rates [odds ratio (OR) =0.87, P=0.18] or the number of lymph nodes dissected [standardized mean difference (SMD) =−0.08, P=0.15]. Results from the retrospective subgroup (n=4) were consistent with those of the RCTs. Across all evidence levels, SILS significantly reduced blood loss (SMD =−0.31, P<0.001) and yielded smaller incision lengths (SMD =−2.41, P<0.001). Based on the synthesis of currently available moderate-to-high quality evidence, SILS in LAGC radical resection achieves comparable oncological radicality to MPLS. While SILS significantly enhances perioperative recovery and minimally invasive benefits, the findings are subject to the inherent limitations of the included study designs.